Inhaled ciclesonide in adults hospitalised with COVID-19: a randomised controlled open-label trial (HALT COVID-19)

OBJECTIVE: To assess the efficacy of inhaled ciclesonide in reducing the duration of oxygen therapy (an indicator of time to clinical improvement) among adults hospitalised with COVID-19. DESIGN: Multicentre, randomised, controlled, open-label trial. SETTING: 9 hospitals (3 academic hospitals and 6...

Descripción completa

Detalles Bibliográficos
Autores principales: Brodin, Daniel, Tornhammar, Per, Ueda, Peter, Krifors, Anders, Westerlund, Eli, Athlin, Simon, Wojt, Sandra, Elvstam, Olof, Neumann, Anca, Elshani, Arsim, Giesecke, Julia, Edvardsson-Källkvist, Jens, Bunpuckdee, Sayam, Unge, Christian, Larsson, Martin, Johansson, Björn, Ljungberg, Johan, Lindell, Jonas, Hansson, Johan, Blennow, Ola, Andersson, Daniel Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2023
Materias:
Infectious Diseases
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950582/
https://www.ncbi.nlm.nih.gov/pubmed/36813503
http://dx.doi.org/10.1136/bmjopen-2022-064374

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950582/
https://www.ncbi.nlm.nih.gov/pubmed/36813503
http://dx.doi.org/10.1136/bmjopen-2022-064374

Ejemplares similares